Literature DB >> 8150880

High-performance liquid chromatographic separation of ondansetron enantiomers in serum using a cellulose-derivatized stationary phase and solid-phase extraction.

J W Kelly1, L He, J T Stewart.   

Abstract

R(-)-Ondansetron and S(+)-ondansetron in human serum were resolved and quantified using a stereospecific HPLC method. Each enantiomer and the internal standard prazosin were isolated from serum using a solid-phase extraction procedure on a cyanopropyl column. Recoveries of 97, 96 and 88% were obtained for the R(-)-enantiomer, the S(+)-enantiomer, and the internal standard, respectively. A cellulose-based chiral analytical column (Chiralcel OD) was used with a mobile phase consisting of hexane-95% ethanol-2-propanol-acetonitrile (65:25:10:1, v/v). Linear calibration curves were obtained for each enantiomer in serum in the concentration range 10-200 ng/ml. The limit of quantitation of each enantiomer was 10 ng/ml. The detection limit for each enantiomer in serum using UV detection at 216 nm was 2.5 ng/ml (signal-to-noise ratio of 3).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8150880     DOI: 10.1016/0378-4347(93)80280-h

Source DB:  PubMed          Journal:  J Chromatogr


  1 in total

Review 1.  Ondansetron clinical pharmacokinetics.

Authors:  F Roila; A Del Favero
Journal:  Clin Pharmacokinet       Date:  1995-08       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.